A carregar...
Pilot Trial of a Patient-Specific Cutaneous Electrostimulation Device (MC5-A Calmare(®)) for Chemotherapy-Induced Peripheral Neuropathy
CONTEXT: Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting and persistent consequence of numerous classes of antineoplastic agents, affecting up to 30%–40% of patients. To date, there is no effective prevention or therapy. An evolving hypothesis for reducing CIPN pain involv...
Na minha lista:
| Publicado no: | J Pain Symptom Manage |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4383258/ https://ncbi.nlm.nih.gov/pubmed/20813492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpainsymman.2010.03.022 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|